Saudi FDA Cancels the Registration of Aupent Product

<p align="justify">
The Saudi FDA has announced the cancellation of Alupent® 10mg L 5 mo syrup ( orciprenaline sulphate) registration due to its hazards on heart and the availability of more safe alternative drugs.<br />Accordingly, drug products and manufacturers' registration committee decided to cancel registration of this product and recall it from the market. SFDA also asked the manufacturer to recall any available stocks from the local market to protect the health of the public. SFDA requests all the concerned to use other alternative drugs for patients who are currently using the said product.<br />For further information on drug updates, please visit our drug site on SFDA website on t he following link: <a href="/ar/drug">www.sfda.gov.sa/ar/drug</a></p&gt;